English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/108816
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE
Exportar a otros formatos:

Title

Progranulin deficiency reduces CD K4/6/pRb activation and survival of human neuroblastoma SH-SY5Y cells

AuthorsDe la Encarnación, Ana; Alquézar, Carolina CSIC ORCID; Esteras, Noemí; Martín-Requero, Ángeles CSIC ORCID
KeywordsProgranulin FTLD-TDP
CDK6/pRb
PI3K/Akt
ERK1/2
Cell survival
Apoptosis
Issue Date7-Nov-2014
PublisherHumana Press
CitationMolecular Neurobiology, 2014
AbstractNull mutations in GRN are associated with Frontotemporal Lobar with TDP-43 inclusions (FTLDTDP).However the influence of progranulin (PGRN) deficiency in neurodegeneration is largely unknown. In neuroblastoma cells, silencing of GRN gene causes significantly reduced cell survival after serum withdrawal. The following observations suggest that alterations of the CDK4/6/pRb pathway, secondary to changes in PI3K/Akt and ERK1/2 activation induced by PGRN deficiency, are involved in the control of serum deprivation-induced apoptosis. (i) Inhibiting CDK4/6 levels or their associated kinase activity by sodium butyrate or PD332991 sensitized control SH-SY5Y cells to serum deprivation-induced apoptosis without affecting survival of PGRN deficient cells. (ii) CDK4/6/pRb seems to be downstream of the PI3K/Akt and ERK1/2 signaling pathways since their specific inhibitors, LY294002 and PD98059, were able to decrease CDK6-associated kinase activity and induced death of control SH-SY5Y cells. (iii) PGRN deficient cells show reduced stimulation of PI3K/Akt, ERK1/2 and CDK4/6 activities compared with control cells in the absence of serum. (iv) supplementation of recombinant human PGRN was able to rescue survival of PGRN deficient cells. These observations highlight the important role of PGRN-mediated stimulation of the PI3K/Akt-ERK1/2/CDK4/6/pRb pathway in determining the cell fate survival/death under serum deprivation.
Description36 p.-10 fig.-1 tab.
Publisher version (URL)http://dx.doi.org/10.1007/s12035-014-8965-5
URIhttp://hdl.handle.net/10261/108816
DOIhttp://dx.doi.org/10.1007/s12035-014-8965-5
ISSN0893-7648
E-ISSN1559-1182
Appears in Collections:(CIB) Artículos
Files in This Item:
File Description SizeFormat 
MOLN.2014 (nov.)Martín-Requero.pdf2,16 MBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.